|
Post by babaoriley on May 30, 2017 18:27:14 GMT -5
When I first heard the news this morning, I expected to see MNKD trading .15 or so down. Sometimes, news of a CEO's departure can provide a shot in the arm to a company's stock. I don't see this as one of those times, especially considering his replacement is coming from within the company. For example, if a high profile guy were coming in, with a proven and successful track record, I could see it. But that's not what happened here.
So..... my guess is our stock went up despite the release of the news and Matt. I'm thinking it's due to other matters.
Perhaps Matt was against something that would have been good for the share price? For example, say a larger company, let's call them "Take a Flyer," wanted to buy MNKD for $2.65 per share. And let's say Matt said "no way, not on my watch." And the Board and Mike say to Matt, "maybe not on your watch, but it will happen on ours, goodbye." I mean, you can come up with many such examples. What if there is negotiation on a foreign deal and the other party said, "shucks, it's just too expensive, we'll only do the deal for X (which is 60% of the Y that was tentatively agreed)." Matt says "nope" you unethical _____________, and the Board says, "we need to do it, Matt, including right over your dead body."
So, what did cause the favorable reaction in the market today? Again, I'm sayin' it was not the ouster of Matt and promotion of Mike.
|
|
|
Post by rockstarrick on May 30, 2017 18:37:49 GMT -5
When I first heard the news this morning, I expected to see MNKD trading .15 or so down. Sometimes, news of a CEO's departure can provide a shot in the arm to a company's stock. I don't see this as one of those times, especially considering his replacement is coming from within the company. For example, if a high profile guy were coming in, with a proven and successful track record, I could see it. But that's not what happened here. So..... my guess is our stock went up despite the release of the news and Matt. I'm thinking it's due to other matters. Perhaps Matt was against something that would have been good for the share price? For example, say a larger company, let's call them "Take a Flyer," wanted to buy MNKD for $2.65 per share. And let's say Matt said "no way, not on my watch." And the Board and Mike say to Matt, "maybe not on your watch, but it will happen on ours, goodbye." I mean, you can come up with many such examples. What if there is negotiation on a foreign deal and the other party said, "shucks, it's just too expensive, we'll only do the deal for X (which is 60% of the Y that was tentatively agreed)." Matt says "nope" you unethical _____________, and the Board says, "we need to do it, Matt, including right over your dead body." So, what did cause the favorable reaction in the market today? Again, I'm sayin' it was not the ouster of Matt and promotion of Mike. Stranger things have happened !! Sometimes you need to be able to see just a little outside the box 📦 There has to be a little flexibility or it's not Negotiating, it becomes Dick-Tating 😜 Ther we go with another misspelled word. Im sure we will eventually find out.
|
|
|
Post by babaoriley on May 30, 2017 19:01:14 GMT -5
"Stranger things have happened !!" Ricky, that's one, giant, "no kidding!"
|
|
|
Post by rockstarrick on May 30, 2017 19:05:14 GMT -5
"Stranger things have happened !!" Ricky, that's one, giant, "no kidding!" Have to give props to Ronny Milsap on that one ☝️ Great song, and a great artist 🎶🎵😎
|
|
|
Post by dreamboatcruise on May 30, 2017 19:25:32 GMT -5
I think this is rebound from an oversold position. I suspect what happened today would have happened regardless. Perhaps Peppy can shed some light on whether this seemed outside what the chart tea leaves and cat entrails suggested was coming (sorry Peppy, I jest about that which I am incompetent, but I do suspect we may be in a positive momentum trading cycle).
On the other hand, maybe some institutional investors have been unhappy with Matt and pressuring the BoD... and started some purchasing when the BoD agreed to make changes. That might have been the catalyst that set off the bounce.
|
|
|
Post by cjc04 on May 30, 2017 19:38:45 GMT -5
Interesting Baba,,,, it would explain something that I just couldn't get my head around with today's news...
Which is..... reguardless of what any of us think of Matt (for the record, my opinion is that Matt did some amazing things over the past 18 months considering the sheet show he was handed, assuming of course everything is what we've been led to believe it is for the past 18 months, which I find hard to believe)... I honestly believed Matt's sincerity when he spoke after Al's death of never giving up on his vision for Afrezza and MANNKIND. So, I find it hard to believe he was willingly pushed out the door and took it as a team player...... your idea does let me understand how he could not agree with the rest of the board on a cheap buyout.
How ironic if that $2.50 offer came from Amgen.
|
|
|
Post by mnkdfann on May 30, 2017 20:13:31 GMT -5
So, what did cause the favorable reaction in the market today? Again, I'm sayin' it was not the ouster of Matt and promotion of Mike. I just don't think the move today was a big deal. People are trading it. Sometimes it moves up big, sometimes down. It's had up and down periods like this for (at least) a year or two. Today's huge move, in pre-RS terms, was less than 3 cents. I said a few days ago about how the trading action in MNKD reminded me of ONCYF some months back. The CEO shuffle from out of the blue today did the same.
|
|
|
Post by straightly on May 30, 2017 20:58:43 GMT -5
Interesting Baba,,,, it would explain something that I just couldn't get my head around with today's news... Which is..... reguardless of what any of us think of Matt (for the record, my opinion is that Matt did some amazing things over the past 18 months considering the sheet show he was handed, assuming of course everything is what we've been led to believe it is for the past 18 months, which I find hard to believe)... I honestly believed Matt's sincerity when he spoke after Al's death of never giving up on his vision for Afrezza and MANNKIND. So, I find it hard to believe he was willingly pushed out the door and took it as a team player...... your idea does let me understand how he could not agree with the rest of the board on a cheap buyout. How ironic if that $2.50 offer came from Amgen. I would voted NO if an offer was made at $2.50. Not because of the pain I have suffered but for the potential I am expecting. Assuming Mike has cracked the riddle of Afrezza not selling and had his team figured out to get ONE doctor to START prescribing per week. How many sales we got? We will surpass Sanofi's sales number before the Summer is over (149 + 30 sales * 12weeks = 509 > 421 ). Or we may surpass our refill count of 300 sooner than that, that we KNOW Afrezza IS working with the right dosage? When that happens, MNKD will be worth how much? All this WILL happen, if Mike and his team has cracked the barriers of making a doctor to make this first prescription and continue prescribing. The only evidence I had was that Mike knew our sales numbers were up and that the BOD praised Mike had increased the sales steadily.
|
|
|
Post by babaoriley on May 31, 2017 1:16:42 GMT -5
"All this WILL happen, if Mike and his team has cracked the barriers of making a doctor to make this first prescription and continue prescribing. The only evidence I had was that Mike knew our sales numbers were up and that the BOD praised Mike had increased the sales steadily."
Straightly, if the BOD has praised anyone for increasing sales steadily, that would have been the faintest praise possible. I think Sports and MannMade have been responsible for more Rx than a good part of our crack sales force.
I just hope they can sell it abroad.
|
|
|
Post by peppy on May 31, 2017 6:33:23 GMT -5
When I first heard the news this morning, I expected to see MNKD trading .15 or so down. Sometimes, news of a CEO's departure can provide a shot in the arm to a company's stock. I don't see this as one of those times, especially considering his replacement is coming from within the company. For example, if a high profile guy were coming in, with a proven and successful track record, I could see it. But that's not what happened here. So..... my guess is our stock went up despite the release of the news and Matt. I'm thinking it's due to other matters. Perhaps Matt was against something that would have been good for the share price? For example, say a larger company, let's call them "Take a Flyer," wanted to buy MNKD for $2.65 per share. And let's say Matt said "no way, not on my watch." And the Board and Mike say to Matt, "maybe not on your watch, but it will happen on ours, goodbye." I mean, you can come up with many such examples. What if there is negotiation on a foreign deal and the other party said, "shucks, it's just too expensive, we'll only do the deal for X (which is 60% of the Y that was tentatively agreed)." Matt says "nope" you unethical _____________, and the Board says, "we need to do it, Matt, including right over your dead body." So, what did cause the favorable reaction in the market today? Again, I'm sayin' it was not the ouster of Matt and promotion of Mike. I think the orders were set for Tuesday. I think buyers were there, with or with out the, "news." Afrezza is a fine insulin, "Afrezza, keeps your blood glucose from going up in the first place." What do I think? I think scripts are up, insurance being worked on, and advertising starting in 36 days. I think the market knows, "things have changed" at least I hope so.
|
|
|
Post by sportsrancho on May 31, 2017 6:56:50 GMT -5
When I first heard the news this morning, I expected to see MNKD trading .15 or so down. Sometimes, news of a CEO's departure can provide a shot in the arm to a company's stock. I don't see this as one of those times, especially considering his replacement is coming from within the company. For example, if a high profile guy were coming in, with a proven and successful track record, I could see it. But that's not what happened here. So..... my guess is our stock went up despite the release of the news and Matt. I'm thinking it's due to other matters. Perhaps Matt was against something that would have been good for the share price? For example, say a larger company, let's call them "Take a Flyer," wanted to buy MNKD for $2.65 per share. And let's say Matt said "no way, not on my watch." And the Board and Mike say to Matt, "maybe not on your watch, but it will happen on ours, goodbye." I mean, you can come up with many such examples. What if there is negotiation on a foreign deal and the other party said, "shucks, it's just too expensive, we'll only do the deal for X (which is 60% of the Y that was tentatively agreed)." Matt says "nope" you unethical _____________, and the Board says, "we need to do it, Matt, including right over your dead body." So, what did cause the favorable reaction in the market today? Again, I'm sayin' it was not the ouster of Matt and promotion of Mike. I think the orders were set for Tuesday. I think buyers were there, with or with out the, "news." Afrezza is a fine insulin, "Afrezza, keeps your blood glucose from going up in the first place." What do I think? I think scripts are up, insurance being worked on, and advertising starting in 36 days. I think the market knows, "things have changed" at least I hope so.
I think you're right. We are all still holding our breathe every Friday. I think the market and Mike know:-)
|
|
|
Post by mnholdem on May 31, 2017 8:22:06 GMT -5
It's also possible that the 3rd party payers may get concerned about the "uber" strategy to by-pass them entirely and decide to be more accommodating to cover Afrezza. It's a stretch, I know, but you'd think the idea of cutting them out is on their radar, and perhaps even being discussed in their boardrooms because it could catch on in this country of exorbitant drug pricing.
1. Insurers haven't been very friendly to Afrezza thus far; 2. MannKind recently announced at the ASM that they may cut out the middle man; 3. Insurers... your move!
|
|
|
Post by wmdhunt on May 31, 2017 18:00:12 GMT -5
News of new deals with Brazilian partners was apparently in the background to people in the know, (not me) so that what boosted the SP. That and CaFEFE...
"VALENCIA, Calif. and BELO HORIZONTE, Brazil, May 31, 2017 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq:MNKD) (TASE:MNKD) and BIOMM SA (BVMF:BIOM3) today announced that they have entered into a supply and distribution agreement for the commercialization of Afrezza® (insulin human) Inhalation Powder in Brazil."
|
|
|
Post by sla55 on May 31, 2017 18:10:43 GMT -5
Covfefe you mean? NTIM!
|
|
|
Post by mytakeonit on May 31, 2017 18:20:26 GMT -5
"All this WILL happen, if Mike and his team has cracked the barriers of making a doctor to make this first prescription and continue prescribing. The only evidence I had was that Mike knew our sales numbers were up and that the BOD praised Mike had increased the sales steadily." Straightly, if the BOD has praised anyone for increasing sales steadily, that would have been the faintest praise possible. I think Sports and MannMade have been responsible for more Rx than a good part of our crack sales force. I just hope they can sell it abroad. Well baba louie ... guess your wish/hope came true and they will sell it abroad. Maybe this is a Karma thing ... ??
|
|